Wednesday, 27 December 2017

Iron overload drug might improve leukaemia treatment

Acute myeloid leukaemia (AML) is an aggressive cancer that stops healthy blood cell production. Chemotherapy is the standard treatment, but improvements are needed as the five-year survival rate in patients older than 60 is only 5-15 per cent.  

from Zee News :Zee News - Health http://ift.tt/2leJM6K

Related Posts:

0 comments: